![]() |
|
|
,1
* INSERM U45, Faculté de médecine Laënnec, 7 rue G Paradin 69372 Lyon cedex 08, France and
Laboratoire dEcologie et de Physiologie du Système Digestif, INRA, Centre de Recherche de Jouy-en-Josas, 78352 Jouy en Josas cedex, France
1To whom correspondence should be addressed. E-mail: plaisancie{at}lyon.inserm.fr.
Intestinal mucus is critically involved in the protection of the mucosa. An enzymatic casein hydrolysate and ß-casomorphin-7, a µ-opioid peptide generated in the intestine during bovine casein digestion, markedly induce mucus discharge. Because shorter µ-opioid peptides have been described, the effects of the opioid peptides in casein, ß-casomorphin-7, -6, -4, -4NH2 and -3, and of opioid neuropeptides met-enkephalin, dynorphin A and (D-Ala2,N-Me-Phe4,glycinol5)enkephalin (DAMGO) on intestinal mucus secretion were investigated. The experiments were conducted with isolated perfused rat jejunum. Mucus secretion under the influence of ß-casomorphins and opioid neuropeptides administered intraluminally or intra-arterially was evaluated using an ELISA for rat intestinal mucus. Luminal administration of ß-casomorphin-7 (1.2 x 10-4 mol/L) provoked a mucus discharge (500% of controls) that was inhibited by naloxone, a specific opiate receptor antagonist. Luminal ß-casomorphin-6, -4 and -4NH2 did not modify basal mucus secretion, whereas intra-arterial administration of ß-casomorphin-4 (1.2 x 10-6 mol/L) induced a mucus discharge. In contrast, intra-arterial administration of the nonopioid peptide ß-casomorphin-3 did not release mucus. Among the opioid neuropeptides, intra-arterial infusion of Met-enkephalin or dynorphin-A did not provoke mucus secretion. In contrast, ß-endorphin (1.2 x 10-8 to 1.2 x 10-6 mol/L) induced a dose-dependent release of mucus (maximal response at 500% of controls). DAMGO (1.2 x 10-6 mol/L), a µ-receptor agonist, also evoked a potent mucus discharge. Our findings suggest that µ-opioid neuropeptides, as well as ß-casomorphins after absorption, modulate intestinal mucus discharge. Milk opioidderived peptides may thus be involved in defense against noxious agents and could have dietary and health applications.
KEY WORDS: mucus intestine milk casomorphin opioid
This article has been cited by other articles:
![]() |
H. Ito, M. Satsukawa, E. Arai, K. Sugiyama, K. Sonoyama, S. Kiriyama, and T. Morita Soluble Fiber Viscosity Affects Both Goblet Cell Number and Small Intestine Mucin Secretion in Rats J. Nutr., September 1, 2009; 139(9): 1640 - 1647. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zoghbi, A. Trompette, J. Claustre, M. E. Homsi, J. Garzon, G. Jourdan, J.-Y. Scoazec, and P. Plaisancie beta-Casomorphin-7 regulates the secretion and expression of gastrointestinal mucins through a {micro}-opioid pathway Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1105 - G1113. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Faure, D. Moennoz, F. Montigon, C. Mettraux, D. Breuille, and O. Ballevre Dietary Threonine Restriction Specifically Reduces Intestinal Mucin Synthesis in Rats J. Nutr., March 1, 2005; 135(3): 486 - 491. [Abstract] [Full Text] [PDF] |
||||